Related Experiment Video
Updated: May 18, 2026

Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System
Published on: April 11, 2025
Knockdown of receptor-interacting serine/threonine protein kinase-2 (RIPK2) affects EMT-associated gene expression in
Shuang Wu1, Tatsuo Kanda, Shingo Nakamoto
1Department of Medicine and Clinical Oncology, Chiba University, Graduate School of Medicine, Chuo-ku, Chiba, Japan.
Background:
Receptor-interacting serine/threonine protein kinase-2 (RIPK2) has been reported to be an important regulator of tumor proliferation, differentiation and wound repair. We investigated the effects of RIPK2 knockdown in human hepatoma cells on epithelial-to-mesenchymal transition (EMT)-associated gene expression.
Materials And Methods:
HepG2 cells stably expressing RIPK2-shRNA (HepG2-shRIPK2) were generated after puromycin selection. Total RNAs from HepG2-shRIPK2 and from HepG2-shcontrol cells were isolated and PCR-based arrays were performed to compare the 84 EMT-associated gene expressions.
Results:
We observed that knockdown of RIPK2 down-regulated mRNA expression of jagged 1 (JAG1); plasminogen activator inhibitor-1 (PAI1); regulator of G-protein signalling 2, 24 kDa (RGS2); E-cadherin (CDH1); fibroblast growth factor binding protein 1 (FGFBP1); snail homolog 2 (SNAI2); protein tyrosine phosphatase type IVA, member 1 (PTP4A1); keratin 19 (KRT19); vimentin (VIM); and survival of motor neuron protein-interacting protein 1 (SIP1).
Conclusion:
We found that knockdown of RIPK2 down-regulated nuclear factor kappa B (NF-κB)-dependent PAI1 and VIM gene expressions. RIPK2 might play an important role in hepatic cell migration. These findings could shed new light on carcinogenesis and on liver regeneration.
Insights
Receptor-interacting serine/threonine protein kinase-2 (RIPK2) knockdown reduced epithelial-to-mesenchymal transition (EMT) gene expression in liver cancer cells. This suggests RIPK2 influences hepatic cell migration and could impact liver carcinogenesis and regeneration.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Receptor-interacting serine/threonine protein kinase-2 (RIPK2) is implicated in tumor progression, differentiation, and wound repair.
- Investigating RIPK2's role in hepatocellular carcinoma (HCC) is crucial for understanding liver cancer development.
Purpose of the Study:
- To determine the effect of RIPK2 knockdown on epithelial-to-mesenchymal transition (EMT)-associated gene expression in human hepatoma cells.
- To elucidate RIPK2's potential role in hepatic cell migration.
Main Methods:
- Generated HepG2 cells with stable RIPK2 knockdown using shRNA (HepG2-shRIPK2).
- Utilized PCR-based arrays to compare the expression of 84 EMT-associated genes between HepG2-shRIPK2 and control cells.
Main Results:
- RIPK2 knockdown significantly down-regulated mRNA expression of key EMT markers including JAG1, PAI1, CDH1, SNAI2, KRT19, VIM, and SIP1.
- Specifically, nuclear factor kappa B (NF-κB)-dependent PAI1 and VIM gene expressions were reduced upon RIPK2 knockdown.
Conclusions:
- RIPK2 plays a role in regulating EMT-associated gene expression in hepatoma cells.
- RIPK2 knockdown affects hepatic cell migration, suggesting its involvement in liver carcinogenesis and regeneration processes.
More Related Videos
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
10:05Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
Related Concept Videos
Receptor Tyrosine Kinases
PI3K/mTOR/AKT Signaling Pathway
Regulation of the Unfolded Protein Response
MAPK Signaling Cascades
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The JAK-STAT Signaling Pathway